Financial Analysis: Omnicell (NASDAQ:OMCL) versus Nyxoah (NASDAQ:NYXH)

Nyxoah (NASDAQ: NYXH - Get Free Report) and Omnicell (NASDAQ: OMCL - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, profitability, risk, institutional ownership and valuation. Volatility and Risk Nyxoah has a beta of 1.56,